Amaero Prices a Smaller $20 Million Nasdaq IPO After September Delay

MCDONALD, Tenn., October 15, 2026 | Amaero reaches Nasdaq today with a financing sized for survival and near-term expansion, rather than a fully funded manufacturing buildout. The Tennessee metal-powder producer priced 4,705,883 shares at $4.25, raising $20.0 million gross and valuing its post-offering equity at roughly $121 million before any exercise of the underwriters' option. The shares are expected to trade as AMRO, with closing scheduled for October 16.

The launch matters because it revives a deal postponed three weeks ago because of adverse market conditions, but on much smaller economics than Amaero first pursued. A September registration amendment contemplated 7,456,500 shares at $7.06, or about $52.6 million gross. The final prospectus lands at 62% less gross capital, with 4.7 million shares sold at a price 40% below that earlier mark. IPOGrid reads the reset as a practical clearing decision: Amaero secured a U.S. listing and fresh cash, while accepting a considerably narrower funding package.

The final bank group is credible for a small industrial issuer. Baird is lead bookrunner and Lake Street is an additional bookrunner. Underwriters have a 30-day option for another 705,882 shares, which would lift gross proceeds to $23.0 million. Amaero expects about $15.7 million net at the base deal size, after $1.4 million of underwriting discounts and other estimated expenses. Up to $10.0 million of net proceeds is earmarked for capital equipment over the next 12 months; the balance will support working capital, operating expenses and research and development. Those terms and the expected trading date were also confirmed in the company's pricing announcement.

Growth is visible, economics are unfinished

Amaero has a public-market narrative with real industrial substance. It makes refractory and titanium alloy spherical powders for additive manufacturing and develops large near-net-shape components through powder metallurgy hot isostatic pressing. Its Tennessee operations serve defense, aerospace, space and naval propulsion programs. The company completed a redomiciliation from Australia to Delaware in June and will retain its ASX-traded CDIs alongside the Nasdaq common stock.

The prospectus shows revenue scaling quickly from a small base. Sales rose 379% to $6.3 million in 2025 from $1.3 million in 2024, then reached $7.4 million in the first half of 2026, up from $1.2 million a year earlier. Metal powders supplied most of that acceleration. Backlog increased from $6.9 million at year-end 2025 to $10.0 million at June 30 and $13.4 million across 18 customers at September 30.

The reviewer’s concern is that volume has yet to produce positive unit economics. Cost of revenue was $11.5 million against $6.3 million of revenue in 2025, leaving a $5.2 million gross loss. In the first half of 2026, $7.4 million of revenue carried $10.5 million of cost, for a $3.1 million gross loss. The gross deficit narrowed slightly from the prior-year half even as sales increased more than sixfold, but Amaero still recorded a $13.4 million first-half net loss.

Customer mix adds another layer of risk. Titomic accounted for 41% of first-half 2026 revenue and Continuum Powders contributed 27%. The two largest customers represented 75% of backlog at June 30. Amaero says its backlog consists of legally binding contracts expected to generate revenue within 12 months, although some PM-HIP orders can be terminated for convenience. Our interpretation is that the growing order book supports the scale-up thesis, but it does not yet demonstrate diversified or profitable production.

The offering buys time, not completion

The balance-sheet disclosure is the clearest reason to watch AMRO after the opening print. Amaero held $13.6 million of cash and $19.6 million of debt at June 30. Preliminary September-quarter estimates put cash at only about $5.0 million after roughly $6.4 million of operating cash use during the quarter. The final prospectus says the IPO proceeds and existing cash should fund operating expenses and capital spending only into the second quarter of 2027. Management also says the offering is insufficient to remove substantial doubt about the company's ability to continue as a going concern for the following 12 months, and that additional funding will be required.

That warning changes how the $20 million headline should be read. Roughly two-thirds of expected net proceeds may go to equipment, yet the company is still absorbing cash while commissioning capacity and qualifying customer programs. The structure appears to us to create a Nasdaq financing channel at a useful moment, but it also makes future dilution or debt a central part of the investment case rather than a remote contingency.

Amaero enters the market with several offsets: fast revenue growth, rising contracted backlog, an industrial reshoring angle and a Baird-led book. It also arrives without disclosed cornerstone demand, with concentrated customers, negative gross profit and less than a year of indicated runway after the IPO. The first trading sessions will show whether public investors reward the defense-manufacturing option value or price the company primarily as an early-stage factory that will need another financing round.